author-photo

Tsvetelina Pentcheva-Hoang

University of Texas MD Anderson Cancer Center

13

Papers

2621

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Abstract 3745: Dual-switch TCR: A two-ligand system to control PRAME TCR-modified T cell proliferation and death using inducible MyD88/CD40 and caspase-9

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

2017 Blood
Show All
- Source
- Cite
- Save
Citations (24)
Abstract B078: GoTCR: Inducible MyD88/CD40 (iMC) enhances proliferation and survival of tumor-specific TCR-modified T cells and improves antitumor efficacy in myeloma

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract IA15: Functional diversity of the pancreas tumor stroma

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis.

2015 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (511)
Erratum to Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival [Cancer Cell 25, 719-734; (2014)]

2015 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (92)
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.

2009 Immunological Reviews
Show All
- Source
- Cite
- Save
Citations (187)
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability

2007 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (77)
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.

2004 Immunity
Show All
- Source
- Cite
- Save
Citations (351)